{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:20:56Z","timestamp":1787757656099,"version":"build-2784847793"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Ceftriaxone has been increasingly used in pediatric population, due to its bacteriological and pharmacokinetic features. Association between ceftriaxone and biliary sludge\/pseudolithiasis formation has been documented in the literature. More rarely, biliary symptoms and cholecystitis during ceftriaxone therapy have been reported. We present a case of acute cholecystitis related to ceftriaxone administration and its management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jmu.jmu_132_20","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T01:12:07Z","timestamp":1639703527000},"page":"288-290","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Ceftriaxone-induced Acute Cholecystitis"],"prefix":"10.4103","volume":"29","author":[{"given":"Fernanda Marta","family":"Gomes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipa","family":"Costeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20240830","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/02841850510015983","article-title":"Ultrasonographic findings in ceftriaxone: Associated biliary sludge and pseudolithiasis in children","volume":"46","author":"Ozturk","year":"2005","journal-title":"Acta Radiol"},{"key":"R2-11-20240830","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/jcu.20228","article-title":"Ceftriaxone-associated biliary pseudolithiasis in children","volume":"34","author":"Biner","year":"2006","journal-title":"J Clin Ultrasound"},{"key":"R3-11-20240830","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/BF02012198","article-title":"Biliary pseudolithiasis in a child associated with 2 days of ceftriaxone therapy","volume":"24","author":"Blais","year":"1994","journal-title":"Pediatr Radiol"},{"key":"R4-11-20240830","doi-asserted-by":"crossref","first-page":"132452","DOI":"10.1155\/2009\/132452","article-title":"Acute cholecystitis caused by ceftriaxone stones in an adult","volume":"2009","author":"Becker","year":"2009","journal-title":"Case Rep Med"},{"key":"R5-11-20240830","first-page":"e080108","article-title":"Pharmacological treatment of ceftriaxone-related cholelithiasis in children: Is it worthwhile?","volume":"8","author":"Oggiano","year":"2019","journal-title":"J Pediatr Neonatal Individ Med"},{"key":"R6-11-20240830","first-page":"7502","article-title":"Ceftriaxone associated biliary pseudolithiasis in a child: A case report and review of the literature","volume":"11","author":"Du","year":"2018","journal-title":"Int J Clin Exp Med"},{"key":"R7-11-20240830","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0140-6736(88)90596-X","article-title":"Reversible ceftriaxone-associated biliary pseudolithiasis in children","volume":"2","author":"Schaad","year":"1988","journal-title":"Lancet"},{"key":"R8-11-20240830","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/0016-5085(90)90486-K","article-title":"Pathogenesis of ceftriaxone-associated biliary sludge. In vitro studies of calcium-ceftriaxone binding and solubility","volume":"99","author":"Shiffman","year":"1990","journal-title":"Gastroenterology"},{"key":"R9-11-20240830","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/(SICI)1097-0096(200005)28:4<166::AID-JCU2>3.0.CO;2-G","article-title":"Sonographic assessment of ceftriaxone-associated biliary pseudolithiasis in children","volume":"28","author":"Palanduz","year":"2000","journal-title":"J Clin Ultrasound"},{"key":"R10-11-20240830","doi-asserted-by":"crossref","first-page":"ofz279","DOI":"10.1093\/ofid\/ofz279","article-title":"Comparison of adverse drug reactions between patients treated with ceftaroline or ceftriaxone: A single-center, matched cohort study","volume":"6","author":"Jansen","year":"2019","journal-title":"Open Forum Infect Dis"}],"container-title":["Journal of Medical Ultrasound"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/JMU.JMU_132_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:48:25Z","timestamp":1787755705000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/JMU.JMU_132_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/jmu.jmu_132_20","relation":{},"ISSN":["0929-6441"],"issn-type":[{"value":"0929-6441","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}